What we are waiting26 Jun 2018 22:35
for?
Tyk2 selection, with licences for both by the end of the year. 5-10% upfront payment. With news on lupus.
A buyout may be dependent on the acquirer reducing risk and thus reducing the price, our nice joker is the Chk1.
If we’re honest, we’d like to see a buyout for £375-400 million. It may be possible.
With aurora hopefully the 10/10 syndrome has followed on into limited preclinical, Sir Tim did mention that CRUK has had one that’s been parked up for over a year, with no interest to license.
What’s your thoughts?
Love peace and harmony.